Home | Welcome to Contract Pharma   
Last Updated Friday, November 28 2014
Print

Financial Report: BASi



By Kristin Brooks



Published February 13, 2014
BASi
 
1Q Revenues: $6.2 million (+7%)
 
1Q Loss: $662,000 (earnings were $256 million 1Q12)
 
Comments: Service revenue was up 5% to $4.9 million. Product revenue increased 15% to $1.3 million, primarily due to higher sales of Culex automated sampling systems. Results include the impact of a change in warrant liability of $961,000 and a payment of $1.2 million to the company’s line of credit.
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On